LONG-TERM NEUROSTIMULATOR PROGRAMMING IN A LARGE PROSPECTIVE TRIAL OF SACRAL NEUROMODULATION THERAPY FOR OVERACTIVE BLADDER PATIENTS

被引：0
|
作者：
Siegel, S. [1 ]
Mangel, J. [2 ]
Bennett, J. [3 ]
Comiter, C., V [4 ]
Zylstra, S. [5 ]
Bird, E. [6 ]
Griebling, T. L. [7 ]
Sutherland, S. E. [8 ]
Berg, Chase K. [9 ]
Kan, F. [9 ]
机构：
[1] Metro Urol, Woodbury, MN USA
[2] MetroHlth Med Ctr, Cleveland, OH USA
[3] Mercy Hlth Pelv Med & Urogynecol, St Louis, MO USA
[4] Stanford Univ, Stanford, CA 94305 USA
[5] Milford Reg Med Ctr, Milford, MA USA
[6] Scott & White Healthcare, Dallas, TX USA
[7] Univ Kansas, Lawrence, KS 66045 USA
[8] Univ Washington, Seattle, WA 98195 USA
[9] Medtronic, Minneapolis, MN USA
来源：
NEUROUROLOGY AND URODYNAMICS | 2018年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
435
引用
收藏
页码：S282 / S282
页数：1
相关论文
共 50 条
  • [1] OVERACTIVE BLADDER PATHWAY AND MEDICAL HISTORY IN A LARGE PROSPECTIVE TRIAL OF SACRAL NEUROMODULATION THERAPY FOR OAB PATIENTS
    Comiter, Craig
    Mangel, Jeffrey
    Bird, Erin T.
    Griebling, Tomas L.
    Culkin, Daniel
    Sutherland, Suzette E.
    Bolstrom, Shenita
    Kan, Fangyu
    Siegel, Steven
    NEUROUROLOGY AND URODYNAMICS, 2016, 35 : S67 - S67
  • [2] Baseline symptom severity and therapeutic success in a large prospective trial of sacral neuromodulation therapy for overactive bladder patients
    Noblett, Karen
    Berg, Kellie C.
    Kan, Fangyu
    Siegel, Steven
    NEUROUROLOGY AND URODYNAMICS, 2018, 37 (05) : 1667 - 1671
  • [3] INFECTION RATE AT 12 MONTHS IN A LARGE PROSPECTIVE TRIAL OF SACRAL NEUROMODULATION FOR OVERACTIVE BLADDER PATIENTS
    Bennett, Jason
    Mangel, Jeffrey
    Comiter, Craig
    Zylstra, Samuel
    Bird, Erin
    Griebling, Tomas L.
    Culkin, Daniel
    Sutherland, Suzette E.
    Noblett, Karen
    Berg, Kellie Chase
    Kan, Fangyu
    Siegel, Steven
    NEUROUROLOGY AND URODYNAMICS, 2014, 33 (02) : 176 - 177
  • [4] Detailed analysis of adverse events and surgical interventions in a large prospective trial of sacral neuromodulation therapy for overactive bladder patients
    Noblett, Karen
    Benson, Kevin
    Kreder, Karl
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 (04) : 1136 - 1139
  • [5] DETAILED ANALYSIS OF ADVERSE EVENTS AND SURGICAL INTERVENTION IN A LARGE PROSPECTIVE TRIAL OF SACRAL NEUROMODULATION THERAPY FOR OVERACTIVE BLADDER PATIENTS
    Noblett, K.
    Benson, K.
    Kreder, K.
    NEUROUROLOGY AND URODYNAMICS, 2015, 34 : S237 - S238
  • [6] Prospective Trial of Sacral Neuromodulation for Refractory Overactive Bladder Syndrome in Korean Patients
    Moon, Kyung Hyun
    Han, Ji-Yeon
    Kim, Jang Hwan
    Lee, Ha Na
    Lee, Kyu-Sung
    Lee, Jeong Gu
    Oh, Seung-June
    Yoon, Ha Na
    Choo, Myung-Soo
    LUTS-LOWER URINARY TRACT SYMPTOMS, 2014, 6 (03) : 175 - 179
  • [7] Predictive factors for long-term response to sacral neuromodulation in patients with refractory idiopathic overactive bladder
    Hafez, S.
    Olivier, L.
    Carolus, B.
    Biardeau, X.
    Perrouin-Verbe, M. A.
    EUROPEAN UROLOGY, 2024, 85 : S1765 - S1766
  • [8] Re: Detailed Analysis of Adverse Events and Surgical Interventions in a Large Prospective Trial of Sacral Neuromodulation Therapy for Overactive Bladder Patients Editorial Comment
    Wein, Alan J.
    JOURNAL OF UROLOGY, 2018, 199 (04): : 898 - 898
  • [9] Intermediate-term results of a prospective, multicenter study on remote programming sacral neuromodulation for refractory overactive bladder
    Zhang, Yaoguang
    Meng, Lingfeng
    Zhang, Peng
    Tian, Xiaojun
    Chen, Guoqing
    Li, Yan
    Zhang, Yong
    Xu, Zhihui
    Wei, Zhongqing
    Zhang, Wei
    Ma, Lulin
    Shi, Benkang
    Liao, Limin
    Wang, Jianye
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (05) : 1966 - +
  • [10] LONG-TERM OUTCOMES OF SACRAL NEUROMODULATION IN PATIENTS WITH REFRACTORY OVERACTIVE BLADDER: A RETROSPECTIVE SINGLE-INSTITUTION STUDY
    Kaaki, B.
    Gupta, D.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2019, 30 : S226 - S226
12345